CRBP Stock: Corbus Pharmaceuticals Holdings, Inc. Stock Price, Analysis & Insights
Get live CRBP stock price $7.70, comprehensive Corbus Pharmaceuticals Holdings, Inc. stock analysis, charts, news, and expert forecast. Real-time CRBP stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Corbus Pharmaceuticals Holdings, Inc. operates as a biopharmaceutical firm, concentrating on creating immune modulators designed to combat immuno-oncology and various fibrotic conditions. Its pipeline includes lenabasum, an orally administered small ...
Company Information
- CEO
- Yuval Cohen
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 28
Contact Information
- Website
- https://www.corbuspharma.com
- Address
- 500 River Ridge Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 2.59)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Corbus Pharmaceuticals Holdings, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Corbus Pharmaceuticals Holdings, Inc.
- ⚠Investors should consider how Corbus Pharmaceuticals Holdings, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
96.52M
P/E Ratio (TTM)
-1.34
Beta
2.59
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CRBP with peer companies:
- Price
- $1.63
- Market cap
- 180.97M
- Price
- $0.10
- Market cap
- 14.86M
- Price
- $1.53
- Market cap
- 104.61M
- Price
- $14.20
- Market cap
- 271.02M
- Price
- $17.00
- Market cap
- 236.06M
- Price
- $1.77
- Market cap
- 166.21M
- Price
- $1.21
- Market cap
- 103.93M
- Price
- $3.88
- Market cap
- 145.54M
- Price
- $1.38
- Market cap
- 95.45M
- Price
- $0.81
- Market cap
- 52.99M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.